An immunogenic cathepsin F secreted by the parasitic stages of Teladorsagia circumcincta.
Teladorsagia circumcincta is a common, pathogenic abomasal nematode of sheep. In order to improve disease control in parasite isolates resistant to several anthelmintics, alternative methods must be sought. Sheep develop acquired immunity to T. circumcincta so vaccination is a valid option for control. For this reason, we are investigating parasite excretory/secretory products for molecules, which have potential to invoke protective immunity against T. circumcincta. Here, we describe experiments in which we identified a novel, immunogenic cathepsin F secreted by L4 T. circumcincta. This protease, initially identified by mass spectrometry analysis, is the most abundant molecule in excretory/secretory products released in vitro by T. circumcincta harvested at 5, 6 or 9 days p.i. and is a target of specific, local IgA responses in sheep which are immune to challenge infection. The full-length cDNA encoding this secreted protease was isolated. Sequence and phylogenetic analyses indicated that the protease (designated T. circumcincta cathepsin F-1, Tci-CF-1) belongs to the cathepsin F class and exhibits greatest identity (>60%) to expressed sequence tags present in the Ostertagia ostertagi and Haemonchus contortus expressed sequence tag databases. Tci-CF-1 also displays high identity to hypothetical proteins identified in the genomes of Caenorhabditis elegans and Caenorhabditis briggsae, both proteins having been described as cathepsin F enzymes. Specific inhibitor binding assay of larval excretory/secretory products confirmed the classification of this excretory/secretory component as a cathepsin F. Reverse transcription-PCR studies indicated that Tci-cf-1 is developmentally regulated and is particular to the host parasitic stages of T. circumcincta. The abundance, immunogenicity and temporal expression pattern of Tci-CF-1 make this a potential vaccine candidate for teladorsagiosis.
Redmond
D L
DL
Division of Parasitology, Moredun Research Institute, Pentlands Science Park, Midlothian EH26 0PZ, UK.
Smith
S K
SK
Halliday
A
A
Smith
W D
WD
Jackson
F
F
Knox
D P
DP
Matthews
J B
JB
D000595:Amino Acid Sequence; D000818:Animals; D029742:Caenorhabditis elegans Proteins / Q000276:immunology; D056646:Cathepsin F; D002403:Cathepsins / Q000276:immunology*; D004270:DNA, Circular / Q000276:immunology; D015801:Helminth Proteins / Q000276:immunology; D007070:Immunoglobulin A / Q000032:analysis / Q000302:isolation & purification; D008196:Lymph / Q000276:immunology; D008969:Molecular Sequence Data; D010028:Ostertagia / Q000201:enzymology / Q000276:immunology*; D010029:Ostertagiasis / Q000276:immunology / Q000469:parasitology / Q000662:veterinary*; D010802:Phylogeny; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D016415:Sequence Alignment; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology* / Q000469:parasitology; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods; D013270:Stomach / Q000276:immunology
D029742:Caenorhabditis elegans Proteins; D004270:DNA, Circular; D015801:Helminth Proteins; D007070:Immunoglobulin A; D002403:Cathepsins; D056646:Cathepsin F